Essent ESNT 深 滬
交易中 11-04 11:02:24 美东时间
69.125
+1.415
+2.09%
華盛通- 最 高69.625
- 今 開68.99
- 成交量 8.34万股
- 最 低 68.01
- 昨 收 67.71
- 總市值 62.13亿
- 52周最高 70.065
- 市盈率 靜 10.02
- 換手率 0.09%
- 52周最低 54.99
- 委 比 -92.03%
- 總股本 8987.65万
- 歷史最高 70.065
- 量 比 0.51
- 振 幅 2.39%
- 歷史最低 9.575
- 每 手 1
- 風險率 3.53%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Fiserv Small Business Index Shows Sales Momentum Heading into Holiday Season
Fiserv Small Business Index for October 2026 reached 146, reflecting a 2.3% year-over-year and 0.3% month-over-month sales increase. Restaurants showed steady growth, while gas station sales surged 23.2% year-over-year. Retail sales rose 1.9% year-over-year, with contributions from gas stations and select categories. Essential spending expanded 2.7% year-over-year, outpacing discretionary spending.
11-03 20:00
Prenetics’ IM8 Names Brian J. Rosin as Successor Chief Financial Officer
Prenetics Global Limited announced that Brian J. Rosin will succeed Stephen Lo as Chief Financial Officer, effective December 31, 2026. Rosin, who joined as CFO of IM8 in May 2026, will lead the Company's global finance organization. Prenetics' finance leadership is now based in the United States, aligning with its largest market. Stephen Lo will transition to a Senior Advisor role. The Company will report third-quarter 2026 results on November 1...
11-03 14:05
ESSENT GROUP LTD收涨1.82%，成交额5085.62万美元
11月3日，ESSENT GROUP LTD（ESNT）收涨1.82%，报68.24美元，成交额5085.62万美元，市值61.33亿美元。 行情数据 • 开盘...
11-03 06:01
美股大行评级 | 潜在涨幅332.55%！Viking Therapeutics获上调目标价至118美元，维持"买入"评级
今日重点评级关注：Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从106美元升至118美元；Canaccord Genuity：维持Aclaris Therapeutics"买入"评级，目标价从10美元升至13美元
11-02 18:53
InvenTrust Q3 Core FFO Rises as Same-Property NOI Grows 3.1%
InvenTrust Properties reported higher Q3 2026 Core FFO and 3.1% same-property NOI growth while maintaining its full-year outlook and expanding its Sun Belt portfolio.
10-29 10:14
Rocky Brands (RCKY) Q3 2026 Earnings Call: Sales Rise 13.3%, Guidance Raised
Rocky Brands Q3 2026 sales rose 13.3% to $138.8 million, adjusted EPS reached $1.76, and management raised full-year revenue and EPS guidance.
10-28 08:03
Praxis Precision Medicines Announces Third Quarter 2026 Financial Results Date, Investor Day and November Conference Participation
Praxis Precision Medicines will host an Investor Day on November 12, 2026, in New York, featuring updates on its commercial strategy and pipeline. The event will include presentations on ulixacaltamide for Essential Tremor and relutrigine for SCN2A and SCN8A encephalopathies. Additionally, the company will participate in three investor conferences in November: Guggenheim's Healthcare Innovation Conference on November 9, UBS Global Biopharma Confe...
10-27 20:01
ESSENT GROUP LTD收跌0.15%，成交额3764.93万美元
10月27日，ESSENT GROUP LTD（ESNT）收跌0.15%，报66.7美元，成交额3764.93万美元，市值59.95亿美元。 行情数据 • 开盘...
10-27 05:03
Citigroup Maintains Buy on Essential Properties, Lowers Price Target to $30
Citigroup analyst Nicholas Joseph maintains Essential Properties (NYSE:EPRT) with a Buy and lowers the price target from $36 to $30.
10-27 02:00
Essential Properties Realty Trust Charts Cautious Growth Path
Essential Properties Realty Trust (($EPRT)) has held its Q3 earnings call. Read...
10-24 08:24
